BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 24911433)

  • 1. Refining a personalized mHealth intervention to promote medication adherence among HIV+ methamphetamine users.
    Montoya JL; Georges S; Poquette A; Depp CA; Atkinson JH; Moore DJ;
    AIDS Care; 2014; 26(12):1477-81. PubMed ID: 24911433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perceived risks and amelioration of harm in research using mobile technology to support antiretroviral therapy adherence in the context of methamphetamine use: a focus group study among minorities living with HIV.
    Pasipanodya EC; Kohli M; Fisher CB; Moore DJ; Curtis B
    Harm Reduct J; 2020 Jun; 17(1):41. PubMed ID: 32527276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attitudes, Beliefs, and Willingness Toward the Use of mHealth Tools for Medication Adherence in the Florida mHealth Adherence Project for People Living With HIV (FL-mAPP): Pilot Questionnaire Study.
    Morano JP; Clauson K; Zhou Z; Escobar-Viera CG; Lieb S; Chen IK; Kirk D; Carter WM; Ruppal M; Cook RL
    JMIR Mhealth Uhealth; 2019 Jul; 7(7):e12900. PubMed ID: 31271150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tailoring a mobile health text-messaging intervention to promote antiretroviral therapy adherence among African Americans: A qualitative study.
    Pasipanodya EC; Montoya JL; Watson CW; Marquine MJ; Hoenigl M; Garcia R; Kua J; Gant V; Trambley J; Moore DJ
    PLoS One; 2020; 15(6):e0233217. PubMed ID: 32516317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Supporting Adolescent Adherence in Vietnam (SAAV) study: study protocol for a randomized controlled trial assessing an mHealth approach to improving adherence for adolescents living with HIV in Vietnam.
    DeSilva M; Vu CN; Bonawitz R; Hai LT; Van Lam N; Yen LT; Gifford AL; Haberer J; Linh DT; Sabin L
    Trials; 2019 Feb; 20(1):150. PubMed ID: 30819228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Individual, social, and structural factors affecting antiretroviral therapy adherence among HIV-positive people who inject drugs in Kazakhstan.
    Davis A; McCrimmon T; Dasgupta A; Gilbert L; Terlikbayeva A; Hunt T; Primbetova S; Wu E; Darisheva M; El-Bassel N
    Int J Drug Policy; 2018 Dec; 62():43-50. PubMed ID: 30359872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Individualized texting for adherence building (iTAB) for methamphetamine users living with HIV: A pilot randomized clinical trial.
    Moore DJ; Pasipanodya EC; Umlauf A; Rooney AS; Gouaux B; Depp CA; Atkinson JH; Montoya JL
    Drug Alcohol Depend; 2018 Aug; 189():154-160. PubMed ID: 29958127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 'The phone reminder is important, but will others get to know about my illness?' Patient perceptions of an mHealth antiretroviral treatment support intervention in the HIVIND trial in South India.
    Rodrigues R; Poongulali S; Balaji K; Atkins S; Ashorn P; De Costa A
    BMJ Open; 2015 Nov; 5(11):e007574. PubMed ID: 26525717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "We fear the police, and the police fear us": structural and individual barriers and facilitators to HIV medication adherence among injection drug users in Kiev, Ukraine.
    Mimiaga MJ; Safren SA; Dvoryak S; Reisner SL; Needle R; Woody G
    AIDS Care; 2010 Nov; 22(11):1305-13. PubMed ID: 20640954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, validation and testing of short text messages for an HIV mobile-health intervention to improve antiretroviral treatment adherence in Mexico.
    Pérez-Sánchez IN; Candela Iglesias M; Rodriguez-Estrada E; Reyes-Terán G; Caballero-Suárez NP
    AIDS Care; 2018; 30(sup1):37-43. PubMed ID: 30235937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Staff Perceptions of Preimplementation Barriers and Facilitators to a Mobile Health Antiretroviral Therapy Adherence Counseling Intervention in South Africa: Qualitative Study.
    McCreesh-Toselli S; Torline J; Gouse H; Robbins RN; Mellins CA; Remien RH; Rowe J; Peton N; Rabie S; Joska JA
    JMIR Mhealth Uhealth; 2021 Apr; 9(4):e23280. PubMed ID: 33821806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preintervention Profiles of Information, Motivational, and Behavioral Self-Efficacy for Methamphetamine Use and HIV Medication Adherence Among Gay and Bisexual Men.
    Starks TJ; Millar BM; Lassiter JM; Parsons JT
    AIDS Patient Care STDS; 2017 Feb; 31(2):78-86. PubMed ID: 28092450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Barriers to antiretroviral treatment access for injecting drug users living with HIV in Chennai, South India.
    Chakrapani V; Velayudham J; Shunmugam M; Newman PA; Dubrow R
    AIDS Care; 2014; 26(7):835-41. PubMed ID: 24283220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping patient-identified barriers and facilitators to retention in HIV care and antiretroviral therapy adherence to Andersen's Behavioral Model.
    Holtzman CW; Shea JA; Glanz K; Jacobs LM; Gross R; Hines J; Mounzer K; Samuel R; Metlay JP; Yehia BR
    AIDS Care; 2015; 27(7):817-28. PubMed ID: 25671515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Florida Mobile Health Adherence Project for People Living With HIV (FL-mAPP): Longitudinal Assessment of Feasibility, Acceptability, and Clinical Outcomes.
    Escobar-Viera C; Zhou Z; Morano JP; Lucero R; Lieb S; McIntosh S; Clauson KA; Cook RL
    JMIR Mhealth Uhealth; 2020 Jan; 8(1):e14557. PubMed ID: 31913127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Barriers and facilitators of adherence to antiretroviral drug therapy and retention in care among adult HIV-positive patients: a qualitative study from Ethiopia.
    Bezabhe WM; Chalmers L; Bereznicki LR; Peterson GM; Bimirew MA; Kassie DM
    PLoS One; 2014; 9(5):e97353. PubMed ID: 24828585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient and provider perspectives on cellular phone-based technology to improve HIV treatment adherence.
    Baranoski AS; Meuser E; Hardy H; Closson EF; Mimiaga MJ; Safren SA; Virk P; Luk R; Skolnik PR; Kumar VS
    AIDS Care; 2014 Jan; 26(1):26-32. PubMed ID: 23742640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methamphetamine use and neuropsychiatric factors are associated with antiretroviral non-adherence.
    Moore DJ; Blackstone K; Woods SP; Ellis RJ; Atkinson JH; Heaton RK; Grant I;
    AIDS Care; 2012; 24(12):1504-13. PubMed ID: 22530794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acceptability and feasibility of short message service to improve ART medication adherence among people living with HIV/AIDS receiving antiretroviral treatment at Adama hospital medical college, Central Ethiopia.
    Endebu T; Deksisa A; Dugasa W; Mulu E; Bogale T
    BMC Public Health; 2019 Oct; 19(1):1315. PubMed ID: 31638936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Barriers to and facilitators of antiretroviral therapy adherence in Nepal: a qualitative study.
    Wasti SP; Simkhada P; Randall J; Freeman JV; van Teijlingen E
    J Health Popul Nutr; 2012 Dec; 30(4):410-9. PubMed ID: 23304907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.